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Abstract
Background. There is no consensus regarding the optimum surgical approach to gallbladder cancer. This study reviews the
management of gallbladder cancer in a single unit. Methods. Retrospective study of 73 consecutive patients diagnosed with
gallbladder cancer. Twenty-three patients underwent surgery with curative intent (surgical group), 28 patients underwent
exploratory surgery but had inoperable disease (surgically inoperable group) and 22 patients had inoperable disease
radiologically (radiologically inoperable group). Within the surgical group, nine patients (cholecystectomy group) were
diagnosed with gallbladder cancer after routine cholecystectomy. Results. The inoperable groups had significantly higher
bilirubin and alkaline phosphatase (ALP) than the surgical group (p0.02 and pB0.01, respectively). Age68, white cell
count (WCC)7.6109/L, platelet345109/L, bilirubin16 mol/L, ALP 124 iu/L and sodium 5137 mmol/L
were markers of inoperability. Age, haemoglobin and neutrophil:lymphocyte ratio (NLR) were predictors for survival
following surgery (p0.04, p0.01 and pB0.01, respectively). The surgical and cholecystectomy groups had significantly
higher median survivals than the surgically and radiologically inoperable groups (18.97 and 26.17 months versus 5.03 and
12.20 months, p0.04). Conclusion. Curative surgical resection of gallbladder cancer improved survival. Exploratory
laparotomy which revealed inoperable disease reduced survival. Preoperative WCC, platelet, bilirubin and ALP may be
used as additional discriminators during the investigation and work up prior to surgery.
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Introduction
Carcinoma of the gallbladder is associated with a very
poor prognosis. The overall five-year survival without
aggressive surgical treatment is less than 5% [1,2].
Surgery remains the only curative treatment for
gallbladder cancer. Unfortunately, the majority of
patients have metastatic or locally advanced disease
at presentation [3]. Less than 20% of cases have
disease which is potentially curable by surgical resec-
tion at the time of diagnosis [4].
Surgical management for gallbladder cancer is
variable and a range of different operations are
undertaken for the disease in different centres. This
varies from simple cholecystectomy to extended liver
resection with resection of common bile duct and
lymphadenectomy [57]. However, there is evidence
of long-term survival following radical resection [8],
although, this surgery is associated with significant
morbidity and mortality [9].
Despite the advances in radiological assessment
allowing more accurate preoperative staging of the
disease, a significant proportion of gallbladder cancers
are found to be unresectable at surgical exploration
[4]. A thorough selection process is therefore critical
to ensure that, as few patients are possible with
incurable disease proceeding to surgery. Identification
of factors which may predict tumour unresectability
could prevent patients being subjected to unnecessary
surgical exploration with no potential survival benefit.
This study reviewed the clinical practice in a single
hepatobiliary and pancreatic unit over a 10-year
period with the aim of identifying factors that
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correlate with improved outcome following surgical
intervention for gallbladder cancer.
Methods
Patients
Seventy-three consecutive patients were referred to
the Department of Hepatobiliary and Pancreatic
Surgery at Leicester General Hospital with suspected
gallbladder cancer between 1996 and 2006. We
reviewed retrospectively collected data from medical
records, and therefore, ethical approval is not required
for the study.
Each patient underwent a rigorous assessment
process in an attempt to determine tumour resect-
ability prior to surgery. Patients with resectable
disease radiologically underwent staging laparoscopy
to identify metastatic and miliary disease below the
resolution of conventional radiological imaging. All
suspicious peritoneal and serosal deposits or lymph
nodes were biopsied. Patients with tumour masses
which had favourable anatomical characteristics for
resection and no evidence of widespread disease or
lymph node metastasis proceeded to an extended
right liver resection (right trisegmentectomy), excision
of the common bile ducts, radical lymphadenectomy
(with skeletonisation of the left portal vein and left
hepatic artery) and hepaticojejunostomy using a roux-
en-Y configuration (radical resection). Patients in
whom extended liver resection was deemed not
feasible due to anaesthetic concerns proceeded to
segmental liver resection (IVb/V) with excision of the
common bile duct, radical lymphadenectomy and
hepaticojejunostomy (segmental resection).
Comparison of groups
Comparisons between the groups were made in
respect of the patients’ demographics, socioeconomic
status, tumour characteristics, disease staging, opera-
tive details and serological results. These factors were
further analysed to identify predictors for operability
and survival.
Statistical analysis
Student’s t-, Fisher’s exact and Chi-squared tests were
applied to compare the groups on all variables.
Receiver Operator Characteristics (ROC) curves
were utilised for further analysis of factors that
demonstrated significant differences between the
groups. Survival functions were measured using
Kaplan-Meier survival curves. All statistical analyses
were carried out using SPSS 13.0† for Windows†. A
value of pB0.05 was considered statistically signifi-
cant.
Results
Between 1996 and 2006, 73 patients were diagnosed
with gallbladder cancer in this unit. The surgical
group included 23 patients who underwent surgery
with curative intent. Amongst the patients with
inoperable disease, 28 patients were deemed inoper-
able only at surgical exploration (surgically inoperable
group) and 22 were deemed to have inoperable
disease based on radiological findings (radiologically
inoperable group). Within the surgical group, nine of
the 23 patients had the diagnosis of gallbladder cancer
made following histological examination of the cho-
lecystectomy specimen. These patients were further
studied as a subgroup (cholecystectomy group) in this
study.
The overall median survival for all patients in this
study was 12.4 months. Figure 1 showed that the
median survival were significantly higher for the
surgical group (19.0 months) and the cholecystect-
omy group (26.2 months) as compared to the
surgically inoperable group (5.0 months) and the
radiologically inoperable group (12.2 months), with
a p value of 0.04. It is worth noting that there are six
patients who survived more than 36 months following
surgery with curative intent. Five of these patients are
still alive at the time of writing, with one patient
remaining alive 81.9 months following their original
resection. Overall operative mortality was 5.9%.
Demographics including gender, body mass index
(BMI), socioeconomic status and racial origin, were
comparable among the groups (Table I). The inoper-
able groups were found to be significantly older than
the surgical group (p0.03). The surgically and
radiologically inoperable groups had significantly
higher serum white cell count (WCC), platelet count,
bilirubin and alkaline phosphatase (ALP) levels but
lower sodium concentration at presentation than the
Figure 1. Comparison of survival among the groups (p0.04).
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surgical group (p0.03, p0.04, p0.02, pB0.01
and pB0.01, respectively).
On comparison of preoperative serological results
between the surgical group and the surgically inoper-
able group, the latter had a significantly higher
bilirubin, ALP, alanine transaminase (ALT) levels
and a lower sodium concentration compared to the
surgical group with p values of 0.02, 0.01, 0.04 and
0.01, respectively. Other serological studies, including
full blood count, liver and renal function tests were
not notably different between the two groups. There
was no difference in the proportion of patients
requiring biliary stenting to relieve jaundice preopera-
tively (p0.29).
The ROC curve was utilised to analyse the value
of age (68), WCC (7.6109/L), platelet count
(345109/L), bilirubin (16 mol/L), ALP (124
iu/L) and sodium concentration (5137 mmol/L) in
Table I. Comparison of variables between the groups.
Variables
Cholecystectomy
group (n9)
Surgical group
(n23)
Surgically inoperable
group (n28)
Radiologically inoperable
group (n22)
Demographics
Female: male ratio 3.5 1.8 1.8 1.8
BMI (kg/m2) 26 (2332) 24 (1832) 25 (1936) 24 (1726)
Age 66 (4780) 65 (3780) 65 (4483) 75 (5489)
Socioeconomic status
Professional/managerial 4 11 10 8
Skilled non-manual 4 6 12 6
Skilled, manual 1 3 3 5
Not working 0 3 3 3
Racial origin
White 8 16 25 18
White med 0 0 1 0
Asian 0 4 2 3
Black 1 2 0 1
Oriental 0 1 0 0
Preoperative stenting
Percentage (%) stented 11.1% 13.0% 25.0% 4.6%
WCC (109/l) 7.5 (4.811.6) 8.0 (4.516.9) 9.4 (3.720.9) 11.5 (6.723.7)
Neutrophil (109/l) 4.9 (3.28.1) 5.2 (2.114.9) 6.3 (1.717.1) 8.3 (1.220.0)
Lymphocytes (109/l) 1.8 (1.22.6) 1.9 (0.43) 1.8 (0.83.6) 1.7 (0.73.6)
Nl:LR 2.9 (1.44.5) 3.1 (1.124.3) 3.8 (1.019.2) 5.6 (0.526.2)
Haemoglobin (g/dl) 13.6 (12.216.5) 12.7 (9.116.5) 11.7 (8.916.5) 12.4 (7.914.5)
Platelet (109/l) 260 (72325) 251 (72615) 326 (156663) 421 (156716)
Serology
Sodium (mmol/l) 138 (136141) 138 (133143) 136 (127141) 133 (127140)
Potassium (mmol/l) 4.0 (3.54.3) 4.1 (3.44.7) 3.8 (3.25.2) 3.75 (35)
Urea (mmol/l) 4.6 (3.65.5) 5.15 (3.221.5) 4.3 (2.67.1) 5.1 (2.822.3)
Creatinine (mmol/l) 73 (64100) 78 (60309) 74 (56137) 83 (72152)
Albumin (g/l) 42 (3447) 40 (1847) 33 (17135) 33 (2147)
Bilirubin (mmol/l) 10 (516) 11 (4193) 20 (4398) 17 (5514)
ALP (iu/l) 83 (36158) 109 (36324) 244 (561682) 281 (721187)
ALT (iu/l) 22 (1687) 22 (7159) 54 (11223) 32 (9970)
Tumour markers
CA19.9 (Ku/l) 5 (46) 6 (423) 610 (351453) 152 (941280)
CEA (mg/l) 3 (24) 4 (2169) 5 (253) 4 (382)
Survival
Survival (months) 26.2 (0.681.9) 19.0 (0.681.9) 5.0 (0.063.0) 12.2 (1.232.9)
Table II. ROC analysis for markers of resectability.
Variables Criterion Area under ROC curve Sensitivity 95% CI Specificity 95% CI p-Value
Age 68 years 0.638 56.0 41.370.0 69.6 47.186.7 0.041
WCC 7.6109/l 0.638 74.4 57.986.9 50.0 28.271.8 0.564
Platelet 345109/l 0.648 51.3 34.867.6 86.4 65.196.9 0.038
Bilirubin 16 mmol/l 0.659 56.4 39.672.2 86.4 65.196.9 0.024
ALP 124 iu/l 0.802 76.9 60.788.8 77.3 54.692.1 B0.001
Sodium 5137 mmol/l 0.744 69.2 52.483.0 72.7 49.889.2 B0.001
448 S. L. Ong et al.
an attempt to predict patients who would have
inoperable disease at surgical exploration. The chief
outcome variable was tumour resectability. The areas
under the ROC curves plotted were 0.64, 0.64, 0.65,
0.66, 0.80 and 0.74, respectively (Table II). Amongst
the above markers, elevated ALP has the best
predictive value for tumour unresectability.
Kaplan-Meier survival curves were used to further
analyse factors that predict survival within the
surgical group (Table III). The analysis showed that
age (B50), haemoglobin concentration (]11.7 g/dL),
WCC (B9.5109/L), neutrophil (B0.6109/L), neu-
trophil:lymphocyte ratio (NLR) (B3.75) were pre-
dictors for survival in this group of patients with p
values of 0.04, 0.01, 0.01, 0.01 and B0.01, respec-
tively (Figures 26). The TNM (Tumour, Node,
Metastasis) staging of disease was also predictive of
survival (p0.03).
Within the surgical group, 10 patients underwent
radical resection and the remaining 12 patients had
segmental resection. The median survival for those
who underwent radical resection was higher than
those who had segmental resection but the difference
was not statistically significant (24.7 months versus
Table III. Kaplan-Meier analysis for predictors of survival.
Variables
p-Values for surgery with curative
intent group
p-Values for surgically inoperable
group
p-Values for all surgical
exploration
Age B50 years 0.04 ns ns
21]BMIB25 ns ns ns
Gender ns ns ns
Preoperative stenting ns ns 0.03
WCC B9.5109/l 0.01 ns ns B0.01
Neutrophil B0.6109/l 0.01 ns B0.01
Lymphocytes 0.9109/l ns ns ns
NLR B3.75 B0.01 ns 0.02
Haemoglobin ]11.7 g/dl 0.01 ns B0.01
Platelet]325109/l ns ns B0.01
Albumin 35 g/dl ns ns ns
BilirubinB25 mmol/l ns ns ns
ALP B110 iu/l ns ns 0.03
ALP B50 iu/l ns ns ns
Histological grading of tumour B0.01 na B0.01
Clear resection margin (R0) ns na na
Tumour size (525 mm) ns na na
T stage ns na na
N stage B0.01 na 0.01
M stage B0.01 na B0.01
Overall TNM stage 0.03 na 0.03
Estimated blood loss 5300 mls ns na ns
Blood transfusion 51 unit ns na ns
na, Not applicable; ns, Statistically not significant.
Figure 2. Influence of age on survival within the resection group
(p0.04).
Figure 3. Preoperative haemoglobin level affects survival following
resection (p0.01)
Surgical management of gallbladder cancer 449
16.5 months, p0.326). Adenocarcinoma was the
most common histological type, present in 19 of the
22 patients who had surgery with curative intent.
Discussion
Overall five-year survival for patients with advanced
carcinoma of the gallbladder is dismal [1012].
Following complete surgical resection of early stage
disease, the actuarial survival rate had been reported
to be as high as 100% [1315]. However, only a small
proportion of patients have resectable disease at the
time of diagnosis. Early detection of disease is there-
fore crucial to improve overall prognosis.
In this study, the survival following resection with
curative intent is better than that reported in the
literature [1618]. The improved survival is likely to
be due to the careful selection of patients for surgery.
The overall operative mortality in our series is 5.9%
and is comparable to other series [7,19]. Over the 10-
year period, 25% of the gallbladder cancers treated in
this unit were identified incidentally following histo-
logical examination of resected specimen from elec-
tive cholecystectomy. Furthermore, the median
survival in this group of patients following curative
resection is as high as 26.2 months. This highlights
the importance of routine histological examination of
all gallbladder specimens, in spite of reports suggest-
ing otherwise [20].
This study also found that more than half of the
patients selected for curative surgery for gallbladder
cancer did not have resectable disease despite a
rigorous preoperative assessment and staging process.
The median survival for the surgically inoperable
group is significantly lower than that of the radiolo-
gically inoperable group, suggesting that exploratory
surgery has a negative impact on survival. Other
studies have also reported a reduced survival in
patients who underwent non-curative surgical ex-
ploration [4,21,22].
In comparing preoperative variables between the
surgical group and the surgically inoperable group,
this study has identified a number of factors which
could be used to further predict resectability. The
strongest of these factors was serum ALP. Elevated
ALP level is a common finding in patients with
gallbladder cancer [23]. ALP rises as a result of
biliary obstruction due to extrinsic tumour compres-
sion upon the biliary tree. The presence of jaundice
with associated derangement of biochemical markers
may be representative of aggressiveness of the disease
and have a role in predicting tumour unresectability
and survival [24].
Kaplan-Meier survival curve, plotted for NLR,
found it to be a predictor of survival for those who
underwent surgery with curative intent. There is
Figure 4. White cell count and survival within the resection group
(p0.01).
Figure 5. Neutrophil count and survival within the resection group
(p0.01).
Figure 6. Neutrophil:lymphocyte ratio and survival within the
resection group (pB0.01).
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Table IV. Summary of the literature on surgical management of gallbladder carcinoma.
Study Year Type of operation N Age Mortality Morbidity Survival Remarks
Total 90
Cholecystectomy (excluding pT1
disease)
21
Kai et al. [31] 2007 Extended cholecystectomy
(resection of the gallbladder bed,
excluding patient with pT1
disease)
34 Mean 65 (3689) NA NA Five-year survival rates with
pT1, pT2, pT3 and pT4 were
100%, 58%, 23% and 12%,
respectively.Five-year survival
with pN0, pN1, pN2 and pN3
were 70%, 32%, 14% and 0%,
respectively.Five-year survival
with Stage I,II, III, Iva and IVb
were 100%, 77%, 42%, 28%
and 0%, respectively.
Improved survival with more
aggressive surgical approach in
pT2 gallbladder carcinoma.For
pT3/4 patients, five-year
survival despite curative
resection only approached 30%.
Resection of segment 4a and 5
(excluding pT1 disease)
20
Total 53
Scheingraber
et al. [19]
2007 Resection with curative intent
(Individual approach9;
standardized approach21)
21 Mean 67 (3988) 9% 26.4% Median survival following
resection with curative
intent14 months
(standardized approach) versus
seven months (individual
approach).
Anatomical liver resection,
proof for bile duct infiltration,
and in case of tumour invasion,
radical resection and lymph
dissection of the
hepaticoduodenal ligament are
essential to improve outcome of
locally advanced gallbladder
cancer.
Palliative surgery 32
Total 65
Cholecystectomy/ bile duct
resection
17
Non-anatomical wedge resection
/ bile duct resection
19
Sasaki et al. [8] 2006 Segment 45 resection / bile
duct resection
11 Mean 64.3(880) 3.1% 29.2%
overall; 47%
with
concomitant
pancreatico
duodenect-
omy
Number of five-year
survivors26.
24.1% recurrence despite R0
resection.
Extended right 1
Liver resection
pancreaticoduodenectomy
17
Total 94
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Table IV (Continued)
Study Year Type of operation N Age Mortality Morbidity Survival Remarks
Yokomizo et al.
[14]
2006 pN0 70 Mean 68.6 (4891) NA NA Overall five-year
survival79.5%Five-year
survival for pN087.1%five-
year survival for pN155.7%.
All patients in this study had
pT2 gallbladder carcinoma.
pN1 24
Total (58 without EHBD
infiltration, 29 with EHBD
infiltration)
110
Simple cholecystectomy 11
Limited liver resection 24
Sakamoto et al.
[29]
2006 Segment 45 resection 15 Median 67(3280) 11% 24% (for 58
patients
without
EHBD
infiltration)
Five-year survival without
biliary infiltration55%.
Five-year
survival with biliary
infiltration10%.
Biliary infiltration is defined as
cancer infiltration of the wall of
the extra-hepatic bile duct, via
the hepatoduodenal ligament.
Extended right 29
Hepatectomy and
pancreaticoduodenectomy
15
Hepatectomy combined with
lymphadenectomy
8
Total 22 9% 46%
Reddy [9] 2006 Extended hepatic resections 11 Median 54(4580) 0% 45% Actuarial three-year overall
survival72% (median 62
months); Actuarial three-year
recurrence-free survival68%
(median 51months)Number of
three-year survivors3.
Morbidity is significantly higher
in those who underwent bile
duct excision 67% versus 10%
(in those without bile duct
excisionAll R0 resection.
fourpatients had portal vein
embolisation preoperatively.
Segment IVB/V hepatectomy 11 9% 27%
Nagino et al.
[34]
2006 Extended hepatic resections and
extra-hepatic bile duct resection
61 NA 18% NA Number of three-year
survivors10Number of
five-year survivors5Three-
year survival25.3%Five-year
survival17.1%.
All curative resections, all had
portal vein embolisation
preoperatively.
Total 64
Extended hepatic resections 19
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Table IV (Continued)
Study Year Type of operation N Age Mortality Morbidity Survival Remarks
Foster [16]. 2006 Simple cholecystectomy 28 Median 64(3482) NA NA Overall median survival13
months Estimated five-year
survival following extended
hepatic resection42%
Estimated five-year survival
following simple
cholecystectomy22%
Estimated five-year survival
following palliative
resection0%.
Radical liver resection improves
survival in T2-T3 disease as
compared with simple
cholecystectomy.
Palliative resection 17
Total 6421
Kiran [18] 2006 Radical resection 443 Median 73 NA NA Overall median survival8
months.
Surveillance, Epidemiology, and
End Results (SEER) classified
disease into localised, regional
and distant stage.Median
survival for localised stage22
monthsMedian survival for
regional stage8 monthsMe-
dian survival for distant stage
3 months.
Complete/partial cholecystectomy
/ lymph node dissection
3236
Others (including excision/
debulking)
2742
Total 70
Xiao et al. [21] 2005 Radical resection 22 Mean 58 (2684) 4.5% 36% Median survival for radical
versus palliative resection ver-
sus exploratory laparotomy
28 months versus nine months
versus three months.
22 patients had Nevin stage IV
disease; 48 patients had Nevin
stage V disease.
Palliative resection 15
Exploratory laparotomy 33
Total 19 NA NA
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Table IV (Continued)
Study Year Type of operation N Age Mortality Morbidity Survival Remarks
Lai [2] 2005 Resection with curative intent (1
had laparoscopic cholecystectomy,
14 had radical cholecystectomy)
15 NA 7.1% 31.6% Overall five-year
survival19.1% Median
survival following radical
resection24 months.Five-
year survival following resec-
tion with curative intent
57.1%Median survival of five
months
followingpalliative resection
Median survival of three
months following palliative
medical treatment.
Aggressive resection improves
survival results.
Palliative surgical resection 4 0% NA
Palliative medical treatment 28 NA NA
Total 72
Kondo et al.
[35]
2003 Extended hepatic resections 51 Median 69.5(53
79)
19% NA Overall three-year
survival19% three-year
survival without portal vein
involvement28%.
This study only included
patients with Stage IV
gallbladder cancer.
Palliative surgery 21
Total number who had resection
with curative intent
112
Kondo [32] 2002 Extended hepatic resections 56 Median 64(3382) 9% 46% Overall median survival18
months five-year
survival25%.
Other type of resections 56
Total 116 21% 44%
Kondol [30] 2002 Radical resection with curative
intent
80 NA 15% 53% Median survival for stage
III22.2Median survival for
stage IV (M0)12.1
monthsMedian survival for
stage IV (M1)6.6 month-
sMedian
survival after palliative
operation4.7 months.
Portal vein resection /pan-
creaticoduodenectomy did not
contribute to long-term
survival.
Palliative operation 36 33% 42%
Total 68
Yamaguchi et
al. [36]
2002 Simple cholecystectomy 9 Mean 62.8(3382) 10% NA Five-year survival with
perineural invasion versus
without perineural
invasion7% versus 72%.
71% patients had perineural
invasion.
Wedge resection 10
Liver resection 47
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Table IV (Continued)
Study Year Type of operation N Age Mortality Morbidity Survival Remarks
Total 28
Chijiiwa [6] 2001 Extended cholecystectomy / radi-
cal resection
22 Mean 62.5 3.6% 14% Five-year survival following
extended cholecystectomy/
radical resection59%Five-
year survival following simple
cholecystectomy17%.
All patients in this study had
pT2 gallbladder carcinoma.
Simple cholecystectomy 6
Total 58 3.4%
Endo et al. [37] 2001 Simple cholecystectomy 8 NA 0% NA Cumulative five-year survival
rate following curative
resection38.1%Number of
three-year survivor2.
Hepatoduodenal ligament
invasion predicts poor surgical
outcome.
Liver resection  bile duct
resection
49 4.1%
Total resections with curative in-
tent
100 3.9%
Fong [22] 2000 Minor liver resection 58 Median 65 0% 48% Median survival26
monthsActuarial five-year
survival38%Median survival
for those who had non-curative
operation8 months, with
actuarial five-year survival of
3%.
Preoperative jaundice and
operative blood loss predicted
mortality.
Extended liver resection 42 10%
Total 86
Benoist [7] 1998 Radical resection (partial
hepatectomy, regional
lymphadenectomy, common bile
duct resection)
21 Median 65(4293) 3.5% 6% Actuarial overall five-year
survival26% Median survival
following radical resection8
monthsActuarial five-year
survival following simple
cholecystectomy44% (Stage
I); 22% (Stage II); 0%
(Stage III).
Amongst the radical group eight
of 21 had nodal metastasis.
Actuarial five-year survival
0% with nodal metastasis and
43% without nodal metastasis.
Simple cholecystectomy 65
Total 70
Cholecystectomy 35
Yamaguchi
[38]
1997 Extended cholecystectomy
(cholecystectomyliver bed
resection)
23 Mean68.5(3292) 5.7% NA Survival rate pT1100%
(five-year)Survival rate
pT322% (three-year)
Survival rate pT420%
(one-year).
Cholecystectomy was adequate
for pT1 gallbladder carcinoma.
Extended cholecystectomy or
hepatectomy with extrahepatic
bile duct resection and lymph
node dissection were justified
for pT2 gallbladder carcinoma.
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evidence that NLR is a prognostic factor for color-
ectal cancer [25] and a predictor of postoperative
complications [26]. It is possible that NLR acts as a
marker of the tumour-induced systemic inflammatory
response and hence is an indirect index of tumour
burden. More recent reports suggest that NLR may
be clinically valuable in a number of hepatobiliary
malignancies, including the prediction of survival
following resection of colorectal liver metastases
[27] and resectability of pancreatic cancer [28].
A review of the existing literature on the surgical
treatment of gallbladder cancer demonstrates that
there is no consensus for the management or the
surgical approach in those patients. Table IV shows
the available literature on the surgical management of
gallbladder cancer. Surgical options ranging from
simple cholecystectomy to extended liver resection
/ bile duct resection / pancreaticoduodenect-
omy have been described and recommended for all
stages of gallbladder cancer [8,18,29]. The literature
consistently report an improved survival following
radical resection with curative intent [2,30,31] de-
spite the increased perioperative morbidity [9,32]. In
spite of this, outcomes from centre to centre following
surgery with curative intent were highly variable, with
median survivals ranging from seven to 28 months
[19,21].
Palliative surgery may carry the benefit of improv-
ing the quality of life in these patients. For example,
segment III hepaticojejunostomy can be an effective
and reliable means of palliation for those with hilar
obstruction secondary to gallbladder carcinoma [33].
However, it is important to note that exploratory
laparotomy where tumour resection was abandoned
due to inoperability has been associated with extre-
mely poor outcome. This is supported by a number of
studies [4,21,22] and makes a search for preoperative
markers that may indicate tumour unresectability
even more important. Confidence in these predictive
values would enable us to avoid subjecting patients to
unnecessary surgical exploration which may have a
negative impact on their survival.
Conclusion
A more standardised management approach for the
early detection of gallbladder cancer and radical
resection provides a better chance of cure for this
disease. Radical resection offers the best probability
of long-term survival but is associated with an
increased morbidity and mortality. In patients, whose
functional status precludes this type of surgery, a
more conservative approach such as a segmental liver
resection may be required. Surgical exploration
where unresectable disease is encountered reduces
survival significantly. Hence, diligent preoperative
evaluation of all gallbladder cancers is essential to
optimise the survival and quality of life in these
patients. A more standardised approach in theT
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surgical management of gallbladder cancer would in
addition facilitate the future comparisons between
different series.
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